In the animal model of AD, Trem2-deficient microglia were unable to transition to a late-stage DAM profile (DAM stage 2), as confirmed by single-cell RNA sequencing (scRNA-seq) analysis (Keren-Shaul et al., 2017). Here, TREM2 is linked to Alzheimer disease.